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Abstract Since the introduction of fast diagnostic tracks in
many areas of oncology, the traditional processing of bone
marrow biopsies (BMB), requiring either resin embedding or
lengthy fixation and decalcification, is due to an upgrade.
Thanks to a growing number of new commercially available
tissue processors, microwave-enhanced processing is becom-
ing a standard tool in the pathology laboratory, allowing rapid
fixation and decalcification of BMB with preserved morphol-
ogy and antigens. In this short report, we describe the use of a
commercially available EDTA-based decalcification fluid
(USEDECALC, Medite, Orlando, USA) in combination with
the LOGOS J (Milestone, Bergamo, Italy), a closed
microwave-enhanced tissue processor, for overnight fixation,
decalcification, and paraffin impregnation of the BMB. This
allows next-day reporting without impaired morphology or
immunohistochemistry, and even improved DNA quality of
the BMB.
Keywords Bonemarrow examination . Decalcification
technique
Introduction
Many systemic diseases, including auto-immune and infec-
tious diseases, but also various malignancies present or orig-
inate in the bone marrow. Despite developments in immune
flow cytometry and molecular diagnostics of blood and bone
marrow, the trephine bone marrow biopsy (BMB) remains a
crucial diagnostic, staging, and prognostic tool in
hematopathology. Immunohistochemistry and molecular
techniques on the BMB complete traditional morphology [1,
2], requiring preservation of antigens, DNA, and RNA. Due to
the growing importance of single day stays in the outpatient
clinics, the pressure to shorten turnaround times of BMB in-
creases. This requires redesigning the process of fixation and
decalcification of BMB, which traditionally required up to
5 days.
The combination of the hard, bony structures, and the
enclosed delicate cells with many different nuclear and cyto-
plasmic structures, containing enzymes that have to be pre-
served, make processing of BMB a challenge. Over the years,
various fixatives have been developed to improve morpholo-
gy or speed up the fixation from the traditional 24–48 h re-
quired with standard formalin, but these fixatives are not nec-
essarily suitable for immunohistochemistry and molecular
techniques. Therefore, formalin-based fixatives are still pre-
ferred in most pathology laboratories. Although resin embed-
ding allows cutting of the bone with optimal preservation of
cytological details, decalcification followed by paraffin em-
bedding is nowadays mostly preferred, since the loss of cellu-
lar detail by decalcification can be compensated by
cytomorphology of the aspirate, supplemented with immuno-
histochemistry on the BMB.
Both decalcification and resin embedding slow the process-
ing of BMB considerably, requiring up to two additional days.
Acidic fluids such as formic acid were introduced to speed up
the decalcification process, however, compromising morphol-
ogy, immunohistochemistry, enzyme reaction, and DNA/
RNA quality. As an alternative, 24- to 48-h formalin fixation,
followed by ultrasound [3] or microwave [4] accelerated de-
calcification in EDTA, was introduced, leading to an
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improved turnaround time and good diagnostic quality. We
further improved our previous BMB protocol to reach a turn-
around time of 2 days (Table 1) with equal morphological,
immunohistochemical, and DNA quality.
The biopsy
The thickness and bone density of the tissue determine the
minimum time for fixation and decalcification. Our new, over-
night protocol allows nomore than 2-mm-thick bone samples.
Therefore, we use a Perspex mold (Klinipath, Duiven,
Netherlands, Fig. 1) to splice the BMB lengthwise. This re-
quires 3–4-mm-thick, good-quality biopsies. In our hospital,
hematologists and physician assistants useMacom 8G needles
(Lettix, Apeldoorn, Netherlands). The splicing of the BMB
enabled us to directly compare the results of our previous
and new protocol by processing each half with a different
protocol. No cutting artifacts were observed after splicing pro-
cedure. For clinical validation, 198 BMB were thus compared
for routine histochemical stains and a set of relevant immuno-
histochemical stains. All illustrations in this report are com-
parisons from this set of patients.
Fixation
Traditionally, we have used Burkhardt’s fixative, a 12 % buff-
ered formaldehyde solution supplemented with methanol and
glucose, for many years because of the better morphology
than achieved with buffered formaldehyde alone, when using
our previous protocols. We still receive the BMB in
Burkhardt’s, but the current protocol is performed after ex-
changing this fixative for buffered formaldehyde.
Decalcification and processing
The BMB are then processed in the LOGOS J (Milestone,
Bergamo, Italy), a fully automated system that performs
microwave-enhanced fixation, decalcification, and paraffin
impregnation in a closed system. This enables overnight pro-
tocols (Table 1). For rapid decalcification, we use a chelating,
EDTA-based solution (USEDECALC, Medite, Orlando,
USA). Compared to other commercially available
decalcifying solutions that we have tested, this gave the best
results for morphology and DNA yield. Another important
factor that determines the results, notably of the Leder
(chloracetate esterase) stain since this requires an intact en-
zyme, is the maximum temperature that is used during the
whole processing. Restricting the temperature to 60 °C allows
enzyme stains (Fig. 2c; Leder staining) with a slightly better
contrast than with our previous protocol. The technical details
of the program are presented in Table 2. Ta
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Sectioning and staining
The LOGOS J is ran from 5 pm to 6.30 am the next morning.
Thereafter, the BMB are embedded in paraffin blocks, and
4-μm sections are routinely stained with Hematoxylin-Eosin
(H&E), Giemsa, Laguesse, PAS, Perls, and in selected cases
Leder solutions. Of these stains, only the protocol for the
Giemsa staining had to be slightly adapted since the colors
were not as intense as in our previous protocol. Therefore,
we have to vary the differentiation time somewhat from case
to case (Fig. 2b; comparison of Giemsa stain). Iron and fibers
are equally preserved.
Immunohistochemistry and in situ hybridization
Many BMB are performed for clinical suspicion of a
myelodysplastic syndrome. Our standard immunohistochem-
ical protocol for this evaluation consists of antibodies against
CD34, CD117, CD61, CD20, CD3, and CD138. The incuba-
tion protocols did not need any changes after introduction of
Fig. 1 Splicing of the bone marrow biopsy in a Perspex mold
Fig. 2 Routine histochemical
staining results for H&E (a),
Giemsa (b), Leder (c), TdT (d),
and CD79a (e) stain with our
previous protocol and the rapid
processing protocol
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the rapid decalcification, and immunohistochemistry performs
equally well (Fig. 2d, e). We use the Lab Vision Autostainer
480 (ImmunoLogic, Duiven, The Netherlands) for immuno-
histochemistry with a 2-h protocol, allowing sign-out of the
cases the same day as the routine stains become available.
Also, the protocols for in situ hybridization (ISH) for
EBER and fluorescence ISH with probes for BCL2, BCL6,
CCDN1, and MYC perform equally well after the rapid de-
calcification (data not shown).
DNA extraction
For immunoglobulin gene and T cell receptor gene rearrange-
ment studies, the DNA is extracted from 20-μm slides using
proteinase K treatment and ethanol precipitation of the geno-
mic DNA. Subsequent purification of the DNA is performed
with a QIAamp DNA Micro Kit (QIAGEN, Hilden,
Germany). To compare the integrity of the retrieved DNAwith
the previous and new protocols, the concentration was adjust-
ed to 50 ng/μl and a size ladder PCR was performed [5]. The
DNAwas run on an agarose gel by electrophoresis. The max-
imum size of the bands of both protocols was compared with
the size ladder PCR products (Fig. 3). DNA degradation is less
with the new rapid processing, allowing detection of larger
products with this method in six of ten tested biopsies.
Discussion
We optimized different steps of our decalcifying protocol dur-
ing the past years to arrive at our current protocol. Indeed,
alternative agents for rapid decalcification at room tempera-
ture with acceptable DNA and RNA results have been report-
ed. These are mainly combinations with 14 % EDTA or
Table 2 Technical details of the
program steps of the rapid
processing protocol using
LOGOS J
Step Duration
1 Neutral buffered formalin (4 % formaldehyde) 15 min, 37 °C
2 h 15 min, 37 °C
2 USEDECALC 10 min, 40 °C
6 h 50 min, 40 °C
3 Water rinsing 30 min RT
4 Flush mix (ethanol 60 %) 2 min RT
5 Ethanol 100 % 2 min, 50 °C
6 Ethanol 100 % 3 min, 50 °C
7 Ethanol 100 % 10 min, 50 °C
30 min, 55 °C
8 Isopropanol 10 min, 55 °C
30 min, 55 °C
9 Wax/paraffin 10 min, 60 °C
90 min, 60 °C
Fig. 3 Comparison of DNA
quality depicting DNA fragment
size of spliced bone marrow
biopsies processed with the
standard and the rapid
decalcification (Logos) protocol,
showing improved DNA quality
after rapid decalcification
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formic acid (for example, Formical-4 (formic acid/EDTA/
formaldehyde, Decal Chemical Corporation, Tallman, NY),
Formical-2000 (EDTA/formic acid, Decal Chemical
Corporation, Tallman, NY), Immunocal (formic acid,
Decal Chemical Corporation, Tallman, NY), and
Surgipath Decalcifier I (formic acid/methanol/formalde-
hyde, Leica Biosystems) [6]). On the other hand, hydro-
chloric and nitric acid-based agents are not recommended
or show clearly worse results in several studies (for exam-
ple, Nitrical (nitric acid, Decal Chemical Corporation,
Tallman, NY), IMEB (HCL/formic acid, IMEB, San
Marcos, Calif), Surgipath Decalcifier II (HCL/EDTA,
Leica Biosystems), Overnight bone decal (EDTA/HCL,
Decal Chemical Corporation, Tallman, NY), Decal Stat
(HCL/EDTA, Decal Chemical Corporation, Tallman, NY),
and RDO Gold (Hydrochloric acid based, Apex
Engineering Products Corporation, Aurora, IL) [6, 7]).
In conclusion, by adjusting our protocol for the pro-
cessing of BMB, we successfully reduced the processing
time of BMB, allowing sign-out within 24 h of receipt
of the biopsy without compromising the quality of mor-
phology and antigen detection and improved DNA
quality.
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